drugset / Trial / NCT05172349

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

NCT05172349 ↗

Phase 2 Withdrawn TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this open, multicenter pilot trial is to assess the impact of the use of an amniotic membrane on the healing of a persistent epithelial lesion or of a corneal ulcer.

Timeline

Start
2022-04
Primary completion
2022-09
Completion
2022-09

Outcome

Outcome not reported

Stopped (Business): “Change in sponsor's strategy”

Drugs

EvaluationDrugModalityDoseRoute
Subject LV-Visio-AMTRIX Other / unclassified — Other

Indications